Autism Spectrum Disorder (ASDNCT06850948
Experiences of Healthcare for Autistic TGD Adults
An observational study of Autism Spectrum Disorder (ASD, run by University of Nottingham at 1 site in United Kingdom.
Trial summary
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Autism Spectrum Disorder (ASD
- What is being tested?
- Qualitative
- How many people
- 13 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 22 Jul 2025to 28 Sep 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The present study will be promoted via the NHS at the Nottingham Centre for Transgender Health, for which advertisements of the study (see attached document) will be displayed within the clinic
Who may be able to join
- 18 years or older
- Experience of accessing a NHS Gender identity clinics in the United Kingdom
- Identify as transgender and/or gender diverse
- Have a clinical diagnosis of autism
- Communicate in the English Language
- Be able to provide informed consent
Who cannot join
- People who do not meet the inclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Exploring the Experiences of Gender Identity Healthcare for Autistic Transgender/ Gender Diverse Adults
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom
- Conditions
- Autism Spectrum Disorder (ASD
- Being tested
- Qualitative
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QualitativeOther
Interviews collected with participants concerning their experience of gender identity healthcare
What is being measured
The primary outcome is the main question the study is designed to answer.
Interview
Qualitative interview
Measured: From March 2025 to September 2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2025
- Study start22 Jul 2025
- Primary completion11 Sep 2026
- Study completion28 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism Spectrum Disorder (ASDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 13 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nottingham
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06850948
- Sponsor's protocol ID
- 25003
- Status last verified
- Sep 2026
- First submitted
- 26 Feb 2025
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided